Residential exposure to plasticizers and its possible role in the pathogenesis of asthma

Environmental Health Perspectives

Volumn 105, Issue 9, 1997, Pages 972-978

  Øie, Leif ^a   Hersoug, Lars Georg ^b   Madsen, Jørgen Øgaard ^c  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b Scandinavian Biomedical Institute AS   (Denmark)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Asthma; Di(2 ethylhexyl) phthalate; Mono(2 ethylhexyl) phthalate; Plasticizer; Polyvinyl chloride; Prostaglandin; PVC; Thromboxane A2 receptor

Indexed keywords

11 EPIPROSTAGLANDIN F2 ALPHA; PHTHALIC ACID 2 ETHYLHEXYL MONOESTER; PLASTICIZER; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN F2 ALPHA; THROMBOXANE;

AEROSOL; ARTICLE; ASTHMA; ENVIRONMENTAL EXPOSURE; HOUSEHOLD; HYDROLYSIS; INHALATION; LUNG; PARTICULATE MATTER; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0030729948     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.97105972     Document Type: Article

References (59)

1. Toppari J, Christiansen P, Giwercman A, Grandjean P, Guillette L, Jégou B, Jensen T, Jouannet P, Keiding N, Larsen J. Male Reproductive Health and Environmental Chemicals with Estrogenic Effects. Report No. 290. Copenhagen:Ministry of Environment and Energy, Danish Environmental Protection Agency, 1995.
2. Burr M. Is asthma increasing? J Epidemiol Community Health 41:185-189 (1987).
3. Åberg N. Allergic Diseases in Childhood and Adolescence in Relation to Background Factors [Thesis]. Gothenburg University, Gothenburg, Sweden, 1988.
4. Magnus P, Kongerud J, Bakke J. Har vi en astmaepidemi? Tidskr Nor Lægeforen 8(11): 972-975 (1991).
5. Burney P, Chinn S, Rona R. Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-86. Br Med J 300:1306-1310 (1990).
6. Anderson H, Butland B, Strachan D. Trends in prevalence and severity of childhood asthma. Br Med J 308:1600-1604 (1994).
7. Peat J, van den Berg R, Green W, Mellis C, Leeder S, Woolcock A. Changing prevalence of asthma in Australian children. Br Med J 308:1591-1596 (1994).
8. Rimpelä A, Savonius B, Rimpelä M, Haahtela T. Asthma and allergic rhinitis among Finnish adolescents in 1977-1991. Scand J Soc Med 23(1):60-65 (1995).
9. Godfrey S. Childhood asthma. In: Asthma (Clark T, Godfrey S, Lee T, eds). London:Chapman and Hall, 1992;551-604.
10. Richards W. Hospitalization of children with status asthmaticus: a review. Pediatrics 84(1):111-118 (1989).
11. Sivertsen B, Clench-Aas J. Exposure to environmental chemicals relevant for respiratory hypersensitivity: European aspects. Toxicol Lett 86(2,3):143-153 (1996).
12. U.S. EPA. Respiratory Health Effects of Passive Smoking: Lung Cancer and Other Disorders. EPA/600/6-90/006F. Washington, DC:U.S. Environmental Protection Agency, 1992.
13. Martinez F, Cline M, Burrows B. Increased incidence of asthma in children of smoking mothers. Pediatrics 89(1):21-26 (1992).
14. Stoddard J, Miller T. Impact of parental smoking on the prevalence of wheezing respiratory illness in children. Am J Epidemiol 141(2):96-102 (1995).
15. Cunningham J, O'Connor G, Dockery D, Speizer F. Environmental tobacco smoke, wheezing, and asthma in children in 24 communities. Am J Respir Crit Care Med 153:218-224 (1996).
16. Pershagen G, Rylander E, Norberg S, Eriksson M, Nordvall SL. Air pollution involving nitrogen dioxide exposure and wheezing bronchitis in children. Int J Epidemiol 24(6):1147-1153 (1995).
17. Korsgaard J. Mite asthma and residency. A case-control study on the impact of exposure to house-dust mites in dwellings. Am Rev Respir Dis 128:231-235 (1983).
18. Platts-Mills T, de Weck A, Aalberse R, Bessot J, Bjorksten B, Bischoff E, Bousquet J, Van Bronswijk J, ChannaBasavanna G, Chapman M. Dust mite allergens and asthma - a worldwide problem. J Allergy Clin Immunol 83(2,1):416-427(1989).
19. Peat JK, Tovey E, Toelle BG, Haby MM, Gray EJ, Mahmic A, Woolcock AJ. House dust mite allergens. A major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med 153:141-146 (1996).
20. Strachan D, Sanders C. Damp housing and childhood asthma; respiratory effects of indoor air temperature and relative humidity. J Epidemiol Community Health 43:7-14 (1989).
21. Spengler J, Neas L, Nakai S, Dockery D, Spiezer F, Ware J, Raizenne M. Respiratory symptoms and housing characteristics. Indoor Air 4:72-82 (1994).
22. Brunekreef B, Dockery DW, Speizer FE, Ware JH, Spengler JD, Ferris BG. Home dampness and respiratory morbidity in children. Am Rev Respir Dis 140:1363-1367 (1989).
23. Jaakkola J, Jaakkola N, Ruotsalainen R. Home dampness and molds as determinants of respiratory symptoms and asthma in pre-school children. J Expos Anal Environ Epidemiol 3(suppl 1):129-142 (1993).
24. Andrae A, Axelson O, Björksten B, Fredriksson M, Kjellman N-L. Symptoms of bronchial hyper-reactivity and asthma in relation to environmental factors. Arch Dis Child 63:473-478 (1988).
25. Reed C, Swanson M. Indoor allergens: identification and quantification. Environ Int 12:115-120 (1986).
26. Warner J, Little S, Pollock I, Longbottom J, Warner J. The influence of exposure to house dust mite, cat, pollen and fungal allergens in die home on primary sensitisation in asthma. Pediatr Allergy Immunol 1:79-86 (1990).
27. Laitinen L, Heino M, Laitinen A, Kava T, Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 131:599-606 (1985).
28. Frew A. The immunology of respiratory allergies. Toxicol Lett 86:65-72 (1996).
29. Nordman H, Keskinen H, Tuppurainen M. Formaldehyde asthma - rare or overlooked? J Allergy Clin Immunol 75:91-99 (1985).
30. Patterson R, Hargreave F, Grammer L, Harris K, Dolovich J. Toluene diisocyanare respiratory reactions. I. Reassessment of the problem. Int Arch Allergy Appl Immunol 84:93-100 (1987).
31. Bakke J, Aas K, Andersen I, Lindvall T, Nordman H, Wahlberg J. Overfølsomhet i luftveiene og kjemiske stoffer. Vurdering av kjemiske stoffers evne til å fremkalle overfølsomhet i luftveiene. Nordiske seminar- og arbeidsrapporter. Copenhagen:Nordic Council of Ministers 1993.
32. Burge P, Harris M, Lam W, O'Brien I, Patchett P. Occupational asthma due to formaldehyde. Thorax 40:255-260 (1985).
33. Axelsen J, Schaldemose A. The Use of Phthalates in Denmark [in Danish]. Report no. 347.58. Copenhagen:Ministry of Environment and Energy, Danish Environmental Protection Agency, 1984.
34. Sundmark H. Environmental Risk Assessment of Phthalates Used as Plasticisers for PVC. Oslo:Norsk Hydro, 1995.
35. Doelman CJ, Borm PJ, Bast A. Plasticisers and bronchial hyperreactivity [letter]. Lancet 335(8691):725 (1990).
36. Nafstad P, Jaakkola JJ, Hagen JA, Botten G, Kongerud J. Breastfeeding, maternal smoking and lower respiratory tract infections. Eur Respir J 9:2623-2629 (1996).
37. Øie L, Magnus P, Johansen BV. Suspended particulate matter in Norwegian dwellings in relation to fleece and shelf factors, domestic smoking, air exchange rate, and presence of hot wire convection heaters. Environ Int 23(4):465-473 (1997).
38. Nikkari T, Schreibman P, Ahrens E Jr. In vivo studies of stetol and squalene secretion by human skin. J Lipid Res 15:563-573 (1974).
39. Proctor D, Andersen I, eds. The Nose. Upper Airway Physiology and the Atmosphetic Environment, Amsterdam:Elsevier Biomedical Press, 1982.
40. National Health Authority. Retningslinjer for Inneluft-kvalitet. 6-90. Oslo:Statens Helsetilsyn, 1990.
41. Fay M, Brattin W, Donohue J. Toxicological Profile for Di(2-ethylhexyl) Phthalate (DEHP). Atlanta, GA:U.S. Department of Health and Human Services, 1993.
42. Thatcher T, Layton D. Deposition, resuspension, and penetration of particles within a residence. Atmos Environ 29(13):1487-1497 (1995).
43. Barnes P, Fan Chung K, Page C. Inflammatory mediators and asthma. Pharmacol Rev 40(1):49-84 (1988).
44. Chung K. Role of inflammation in the hyperreactivity of the airways in asthma. Thorax 41:657-662 (1986).
45. 2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis 133:252-254 (1986).
46. Jongejan R, de Jongste J, Raatgeep R, Stijnen T, Bonta I, Kerrebijn K. Effects of inflammatory mediators oh the responsiveness of isolated human airways to methacholine. Am Rev Respir Dis 142:1129-1132 (1990).
47. 2 into human airways during acute antigen challenge. N Engl J Med 315(13):800-804 (1986).
48. 2 receptor antagonists in guinea pigs. Eur J Pharmacol 238:335-341 (1993).
49. Gardiner P. Eicosanoids and airway smooth muscle. Pharmacol Ther 44:1-62 (1989).
50. Norel X, Labat C, Gardiner PJ, Brink C. Inhibitory effects of BAY u3405 on prostanoid-induced contractions in human isolated bronchial and pulmonary arterial muscle preparations. Br J Pharmacol 104:591-595 (1991).
51. Doelman C, Borm P, Bast A. Plasticisers, another burden for asthmatics? Agents Actions Suppl 31:81-84 (1990).
52. Schulz C, Rubin R, Hutchins G. Acute lung toxicity and sudden death in rats following the intravenous administration of the plasticizer, di(2-ethylhexyl)-phthalate, solubilized with tween surfactants. Toxicol Appl Pharmacol 33:514-525 (1975).
53. Roth B, Herkenrath P, Lehmann H, Ohles H, Hömig H, Benz-Bohm G, Kreuder J, Younossi-Hartenstein A. Di-(2-ethylhexyl)-phthalate as plasticizer in PVC respiratory tubing systems: indications of hazardous effects on pulmonary function in mechanically ventilated, preterm infants. Eur J Pediatr 147:41-46 (1988).
54. Ariens E. Pharmacology of airway smooth muscle. In: Bronchial Hyperresponsiveness, vol 1 (Nadel J, Pauwels R, Snashall P, eds). Oxford:Blackwell Scientific Publications, 1987;7-22.
55. Shukla R, Albro P, Corbett J, Schroeder J. In vitro studies of the inhibition of protein kinase C from rat brain by di-(2-ethylhexyl) phthalate. Chem Biol Interact 69:73-85 (1989).
56. 2,-and histamine-induced bronchoconstriction in asthma, and relationship to plasma drug concentrations. Br J Clin Pharmacol 34:402-408 (1992).
57. Shahar E, Folsom A, Melnick S, Tockman M, Comstock G, Gennaro V, Higgins M, Sorlie P, Ko W, Szklo M. Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. N Engl J Med 331(4):228-233 (1994).
58. Simopoulos A. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 54:438-463 (1991).
59. Schmidt E, Dyerberg J. Omega-3 fatty acids. Current status in cardiovascular medicine. Drugs 47(3):405-424 (1994).